Renaissance Technologies
TDOC icon

Renaissance Technologies’s Teladoc Health TDOC Stock Holding History

Renaissance Technologies’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.5M Sell
8,072,842
-12,700
-0.2% -$84.5K 0.09% 240
2026
Q1 		$44.1M Buy
8,085,542
+107,400
+1% +$603K 0.07% 358
2025
Q4 		$55.8M Sell
7,978,142
-198,700
-2% -$1.56M 0.09% 259
2025
Q3 		$63.2M Buy
8,176,842
+855,300
+12% +$6.68M 0.08% 272
2025
Q2 		$63.8M Buy
7,321,542
+775,300
+12% +$5.62M 0.08% 260
2025
Q1 		$52.1M Buy
6,546,242
+871,700
+15% +$8.82M 0.08% 306
2024
Q4 		$51.6M Buy
5,674,542
+763,265
+16% +$7.37M 0.08% 311
2024
Q3 		$45.1M Sell
4,911,277
-558,507
-10% -$4.62M 0.07% 353
2024
Q2 		$53.5M Sell
5,469,784
-63,719
-1% -$777K 0.09% 265
2024
Q1 		$83.6M Buy
5,533,503
+658,319
+14% +$11.9M 0.13% 168
2023
Q4 		$105M Buy
4,875,184
+366,200
+8% +$6.76M 0.16% 132
2023
Q3 		$83.8M Buy
4,508,984
+101,165
+2% +$2.36M 0.14% 151
2023
Q2 		$112M Buy
4,407,819
+1,038,319
+31% +$26.1M 0.16% 127
2023
Q1 		$87.3M Buy
3,369,500
+902,100
+37% +$24.1M 0.12% 211
2022
Q4 		$58.4M Sell
2,467,400
-981,519
-28% -$26.5M 0.08% 291
2022
Q3 		$87.4M Sell
3,448,919
-1,026,400
-23% -$36M 0.12% 185
2022
Q2 		$149M Buy
4,475,319
+4,018,300
+879% +$171M 0.18% 114
2022
Q1 		$33M Sell
457,019
-866,988
-65% -$62.5M 0.04% 504
2021
Q4 		$122M Buy
+1,324,007
New +$158M 0.15% 143
2021
Q1 		– Sell
-55,982
Closed -$11.2M – 3699
2020
Q4 		$11.2M Sell
55,982
-611,818
-92% -$124M 0.01% 1088
2020
Q3 		$146M Buy
667,800
+503,600
+307% +$107M 0.15% 128
2020
Q2 		$31.3M Buy
164,200
+115,320
+236% +$20.2M 0.03% 587
2020
Q1 		$7.58M Sell
48,880
-493,820
-91% -$57.5M 0.01% 1332
2019
Q4 		$45.4M Buy
+542,700
New +$41.3M 0.03% 567
2019
Q1 		– Sell
-77,100
Closed -$3.82M – 3691
2018
Q4 		$3.82M Buy
+77,100
New +$4.72M ﹤0.01% 1891

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Renaissance Technologies's TDOC Position: Q2 2026 in Review

Renaissance Technologies reduced its Teladoc Health (TDOC) stake by 0.16% in Q2 2026, selling an estimated $84.5K and leaving 8,072,842 shares worth $68.5M. The position accounts for 0.09% of the portfolio, ranked #240.

Renaissance Technologies first reported a position in TDOC in Q4 2018 and has held it in 25 quarters since. The position peaked at $149M in Q2 2022. 255 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Renaissance Technologies held 8,072,842 shares of Teladoc Health worth $68.5M as of Q2 2026.
  • Renaissance Technologies sold 12,700 Teladoc Health shares in Q2 2026, an estimated $84.5K.
  • Teladoc Health made up 0.09% of Renaissance Technologies's portfolio in Q2 2026, its #240 holding.
  • Renaissance Technologies first reported a position in Teladoc Health in Q4 2018 and has held it in 25 quarters since.
  • Renaissance Technologies's Teladoc Health position peaked at $149M in Q2 2022.
  • 255 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.